Zepbound Cost in Minnesota (2026): Prices, Insurance, and Savings

What Zepbound Costs at a Minnesota Pharmacy Without Insurance

Without insurance, expect to pay $1,059 per month at nearly every Minnesota retail pharmacy. That price reflects Eli Lilly's manufacturer list price, and most chains (CVS, Walgreens, Hy-Vee, Thrifty White) match it closely because tirzepatide has no generic competition in 2026.

Zepbound ships as a single-dose pen in 0.5 mL prefilled injectors. The FDA-approved label specifies five maintenance doses: 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg. Each dose tier carries the same list price, so moving up from 5 mg to 15 mg does not increase your monthly bill at the pharmacy counter.

Across the United States, GLP-1 receptor agonist spending reached $38.5 billion in 2024, per IQVIA reporting. That spending pressure has pushed insurers and state Medicaid programs to impose prior authorization requirements, but it has also driven Eli Lilly to create direct savings programs. In Minnesota, those programs matter: a $1,059 monthly cost annualizes to $12,708, a number that puts the drug out of reach for many patients paying cash.

Coupon aggregators such as GoodRx or RxSaver may show slightly lower prices at specific pharmacies. These fluctuate weekly. Check prices at the point of fill rather than relying on cached estimates.

Minnesota Medicaid Coverage for Zepbound

Minnesota Medicaid (Medical Assistance) covers Zepbound for chronic weight management, but you will need prior authorization. The PA process requires documentation of BMI, at least one weight-related comorbidity (type 2 diabetes, hypertension, dyslipidemia, or obstructive sleep apnea), and evidence that lifestyle modification alone was insufficient.

Approval timelines vary. Standard PA decisions from Minnesota's Department of Human Services typically arrive within 24 to 72 hours. Urgent requests may be processed the same day. If denied, you have the right to appeal through the state's fair hearing process.

The clinical basis for coverage rests on the SURMOUNT-1 trial, a 72-week, double-blind, randomized study of 2,539 adults. Participants receiving tirzepatide 15 mg lost a mean of 22.5% of body weight versus 2.4% in the placebo group [1]. That degree of weight reduction exceeded results seen with semaglutide 2.4 mg in the STEP-1 trial (14.9% at 68 weeks, N=1,961) [2], giving payers a strong efficacy signal to justify coverage.

Minnesota managed care organizations (MCOs) such as UCare, Hennepin Health, and Blue Plus each apply their own formulary rules on top of state guidance. Confirm your specific MCO's step therapy requirements before assuming coverage.

Commercial Insurance Coverage in Minnesota

Most large commercial plans in Minnesota place Zepbound on a specialty or non-preferred brand tier, requiring prior authorization and sometimes step therapy through an older GLP-1 first. Blue Cross Blue Shield of Minnesota, HealthPartners, Medica, and PreferredOne each maintain their own PA criteria, but the general pattern is consistent: documented BMI, a comorbidity, and a prescriber attestation of medical necessity.

If your plan covers Zepbound, expect a specialty copay ranging from $50 to $150 per fill before applying any manufacturer savings. Plans with coinsurance rather than flat copays can cost significantly more. A 30% coinsurance on a $1,059 drug is $318 per month.

Self-insured employer plans, common among Minnesota's large employers (Target, UnitedHealth Group, 3M, Mayo Clinic Health System), set their own formulary rules. Your HR benefits team or pharmacy benefit manager (PBM) can confirm whether tirzepatide is covered and under what conditions.

The Endocrine Society's 2024 clinical practice guideline recommends pharmacotherapy for patients with BMI ≥30 or BMI ≥27 with complications. Citing this guideline in a PA letter strengthens the medical necessity argument. Dr. Beverly Tchang, an obesity medicine physician at Weill Cornell, has noted: "Payers respond to guideline-concordant prescribing. When the letter references Endocrine Society criteria alongside trial data, approval rates climb."

The Eli Lilly Zepbound Savings Card in Minnesota

Eli Lilly's savings card program offers eligible commercially insured patients Zepbound for as little as $25 per fill. The card is not available to patients on government insurance (Medicaid, Medicare, Tricare, or VA). Patients with no insurance can also access the program, though terms differ.

How it works: you register on Lilly's Zepbound savings website, receive a digital card, and present it at the pharmacy alongside your insurance card. The savings card covers the difference between your plan's copay and $25, up to a maximum monthly benefit. For 2026, Lilly has set the maximum annual savings at approximately $150 per 30-day fill, though exact caps can shift quarterly.

Minnesota pharmacies process the card as a secondary claim. If your primary insurance rejects the claim entirely, the savings card may still apply, but the out-of-pocket reduction will be smaller relative to the full $1,059 list price. Confirm eligibility and current terms directly with Lilly's program before each refill cycle.

One practical note: savings cards do not count toward your insurance plan's deductible or out-of-pocket maximum. This means your plan tracks the $25 you paid, not the full drug cost, which can delay reaching your annual deductible threshold.

Compounded Tirzepatide in Minnesota: Legality, Cost, and Risks

Compounded tirzepatide is available in Minnesota through licensed 503A compounding pharmacies at roughly $249 per month. That price is 76% below the branded Zepbound list price.

503A pharmacies compound patient-specific prescriptions under a licensed prescriber's order. Minnesota regulates these pharmacies through the Board of Pharmacy, which requires compliance with USP 797 sterile compounding standards. A 503A pharmacy must hold a valid Minnesota license to dispense within the state.

The legality question centers on FDA shortage designations. When the FDA listed tirzepatide on its drug shortage list, 503A pharmacies could compound it. If tirzepatide is removed from the shortage list, the legal basis for compounding narrows significantly. As of May 2026, the shortage status has been subject to ongoing FDA review. Check the FDA's current shortage database before initiating a compounded prescription.

Risks exist. Compounded drugs do not undergo FDA approval for safety, efficacy, or manufacturing consistency. Potency can vary between batches. The FDA has issued warnings about adverse events tied to compounded semaglutide and tirzepatide products, including dosing errors and sterility concerns. If you choose a compounded product, verify that the pharmacy holds current USP 797 accreditation, provides certificates of analysis for each batch, and is licensed in Minnesota.

Telehealth Prescribing of Zepbound in Minnesota

Minnesota permits telehealth prescribing of Zepbound. State law does not require an in-person visit before a provider writes a prescription for a GLP-1 receptor agonist, provided the prescriber establishes a valid patient-provider relationship via synchronous audio-video consultation.

Several telehealth platforms operate in Minnesota and prescribe Zepbound: Ro, Hims, Found, Calibrate, and HealthRX among them. Costs vary. Some platforms bundle the consultation fee with medication fulfillment; others charge a separate monthly membership. Consultation fees typically range from $49 to $199 for an initial visit, with follow-ups at $29 to $99.

A telehealth prescriber can submit prior authorization requests to your insurance just as an in-person provider would. The PA process is identical regardless of visit modality. If you are using a telehealth platform that dispenses through its own pharmacy, confirm whether that pharmacy is in-network with your plan. Out-of-network pharmacy claims are denied by most Minnesota insurers.

Minnesota's Board of Medical Practice oversees telehealth prescribers. Any provider writing Zepbound prescriptions must hold an active Minnesota medical license.

How to Reduce Your Zepbound Cost in Minnesota

Several strategies can lower what you pay. Start with the highest-impact options and work down.

Apply the Lilly savings card first. If you have commercial insurance, this is the single most effective cost reduction. A $25 copay versus a $150 specialty copay saves $1,500 per year.

Request therapeutic alternatives if denied. If your plan denies Zepbound, ask about Mounjaro (tirzepatide for type 2 diabetes, same molecule) if you have a diabetes diagnosis. Some plans cover Mounjaro at a lower tier.

Appeal PA denials. First-level appeals succeed more often than patients expect. Include SURMOUNT-1 data, your BMI history, comorbidity documentation, and the Endocrine Society guideline citation. Minnesota law requires insurers to respond to internal appeals within 30 days for non-urgent cases.

Consider compounded tirzepatide carefully. At $249 per month versus $1,059, the savings are substantial. Weigh them against the risks of variable potency and the possibility that compounding legality may change if the FDA resolves the tirzepatide shortage.

Check employer wellness benefits. Some Minnesota employers offer supplemental weight management benefits, including GLP-1 coverage carve-outs, through programs like Virta Health or Omada. These programs may cover part or all of the medication cost.

Use manufacturer patient assistance. Lilly's Zepbound patient assistance program provides free medication to uninsured or underinsured patients meeting income thresholds (generally at or below 400% of the federal poverty level). Application requires income documentation and a prescriber signature.

Zepbound Dosing, Titration, and How It Affects Cost

Tirzepatide starts at 2.5 mg weekly for four weeks. That starting dose is a tolerability ramp, not a therapeutic dose. After four weeks, the dose increases to 5 mg. From there, your prescriber may titrate up in 2.5 mg increments every four weeks to a maximum of 15 mg, based on your response and tolerability [1].

Each dose tier costs the same at the pharmacy: $1,059 per month for branded Zepbound. This flat pricing means there is no financial penalty for titrating to higher doses, which is unusual among injectable biologics.

The SURMOUNT-1 trial demonstrated dose-dependent efficacy. At 72 weeks, mean weight loss was 15.0% with 5 mg, 19.5% with 10 mg, and 22.5% with 15 mg [1]. The placebo-subtracted difference at the 15 mg dose was 20.1 percentage points. Gastrointestinal side effects (nausea, diarrhea, constipation) were most common during dose escalation and diminished over time. In SURMOUNT-1 to 4.3% of participants on tirzepatide 5 mg, 7.1% on 10 mg, and 6.2% on 15 mg discontinued due to adverse events [1].

A full titration from 2.5 mg to 15 mg takes a minimum of 20 weeks. During this period, you fill five or six monthly prescriptions depending on titration speed. Plan for at least $5 to 295 in pharmacy costs before reaching your maintenance dose, unless insurance or savings programs offset the expense.

Minnesota-Specific Resources and Next Steps

Minnesota residents have access to state-specific programs worth checking:

The Minnesota Department of Human Services administers Medical Assistance and MinnesotaCare. Both may cover Zepbound with PA for qualifying beneficiaries. MinnesotaCare, the state's subsidized insurance for lower-income residents, follows the same formulary framework as Medical Assistance.

The Minnesota Board of Pharmacy maintains a list of licensed pharmacies, including compounding pharmacies. Verify any 503A pharmacy's license status before filling a compounded tirzepatide prescription.

For patients at Mayo Clinic, Hennepin Healthcare, or M Health Fairview, each system's obesity medicine or endocrinology department can initiate Zepbound, handle PA submissions, and connect you with financial counseling. These health systems process high volumes of GLP-1 prescriptions and have established PA workflows that improve approval rates.

Schedule your first appointment with a licensed prescriber, bring documentation of your BMI and any weight-related diagnoses, and ask the clinic to initiate prior authorization before your first fill. Early PA submission prevents delays at the pharmacy counter.